Canada - English - Health Canada

jamp pharma corporation - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Canada - English - Health Canada

avanstra inc - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Canada - English - Health Canada

pharmascience inc - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Canada - English - Health Canada

apotex inc - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 2 mg - risperidone (risperidone) is indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies ( 14.1) ]. monotherapy risperidone is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies ( 14.2) ]. adjunctive therapy risperidone adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies ( 14.3) ]. pediatrics risperidone is indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injuriousness, temper

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 0.5 mg - risperidone (risperidone) is indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies ( 14.1) ]. monotherapy risperidone is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies ( 14.2) ]. adjunctive therapy risperidone adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies ( 14.3) ]. pediatrics risperidone is indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injuriousness, temper

Canada - English - Health Canada

dominion pharmacal - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - risperidone -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - risperidone -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - risperidone -